Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB26FWEYN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,893
Award facts
- Contract value 100% obligated
- $1,892.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,892.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUCALA 100 mg/ml auto-injector units. This delivery order, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, operates under a firm fixed-price contract structure with no set-aside designation. The award represents a specific purchase order executed through DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) relationship with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's single-award IDC with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499,999,999 with a completion date of December 31, 2036. As one of multiple regional prime vendor contractors under the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group serves as a critical supplier of pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The company's established track record of delivering diverse pharmaceutical products—including biologics, specialty medications, and routine pharmaceuticals—demonstrates its capability to support recurring military healthcare supply requirements across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DB26FWEYN?
SPE2DB26FWEYN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FWEYN worth?
The government has obligated $1,893 on SPE2DB26FWEYN.
Is contract SPE2DB26FWEYN an order under another contract?
Yes. SPE2DB26FWEYN is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB26FWEYN competed?
The extent of competition for SPE2DB26FWEYN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award